These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25781039)

  • 1. Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply.
    Gerich M; Yoon J; Vasiliauskas E
    Aliment Pharmacol Ther; 2015 Apr; 41(8):786. PubMed ID: 25781039
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: is thalidomide a good option for patients with refractory Crohn's disease?
    Rogler G
    Aliment Pharmacol Ther; 2015 Apr; 41(8):785-6. PubMed ID: 25781038
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide and refractory Crohn's disease: what is in the future?
    Ng SC
    J Clin Gastroenterol; 2014 Jul; 48(6):476-7. PubMed ID: 24781387
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide in oral Crohn's disease refractory to conventional medical treatment.
    Odeka EB; Miller V
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide for Crohn's disease.
    Fishman SJ; Feins NR; D'Amoto RJ; Folkman J
    Gastroenterology; 2000 Aug; 119(2):596. PubMed ID: 10960273
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in refractory vulvar ulcerations associated with Crohn's disease.
    Kolivras A; De Maubeuge J; André J; Song M
    Dermatology; 2003; 206(4):381-3. PubMed ID: 12771492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of thalidomide in refractory Crohn's disease.
    Gerich ME; Yoon JL; Targan SR; Ippoliti AF; Vasiliauskas EA
    Aliment Pharmacol Ther; 2015 Mar; 41(5):429-37. PubMed ID: 25511905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of thalidomide for refractory esophageal Crohn's disease.
    Barkin JA; Schonfeld WB; Deshpande AR
    Am J Gastroenterol; 2013 May; 108(5):855-7. PubMed ID: 23644969
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature.
    Ginsburg PM; Dassopoulos T; Ehrenpreis ED
    Ann Med; 2001 Nov; 33(8):516-25. PubMed ID: 11730158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide improves clinical remission in children with Crohn's disease.
    Harbour S; Brown N
    Arch Dis Child Educ Pract Ed; 2015 Apr; 100(2):111. PubMed ID: 25721487
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness and security of thalidomide for gastrointestinal bleeding and severe Crohn's disease in children].
    Bauditz J
    Z Gastroenterol; 2014 Oct; 52(10):1198-201. PubMed ID: 25313632
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104.
    Cohen LB
    Can J Gastroenterol; 2004 Jun; 18(6):419; author reply 419. PubMed ID: 15230268
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of placebo in a trial of thalidomide for pediatric Crohn disease--reply.
    Lazzerini M; Martelossi S; Ventura A
    JAMA; 2014 Mar; 311(12):1251-2. PubMed ID: 24668112
    [No Abstract]   [Full Text] [Related]  

  • 14. Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy.
    Hershfield NB
    Can J Gastroenterol; 2004 Feb; 18(2):101-4. PubMed ID: 14997219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all?
    Katz JA
    Inflamm Bowel Dis; 2000 May; 6(2):152-3. PubMed ID: 10833076
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Lazzerini M; Martelossi S; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1752-3. PubMed ID: 25993695
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thalidomide in refractory Crohn's disease: long-term efficacy and safety].
    Xu S; Zu XM; Feng R; Zhang SH; Qiu Y; Chen BL; Zeng ZR; Chen MH; He Y
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):445-450. PubMed ID: 32486585
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
    Hegarty A; Hodgson T; Porter S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide induces mucosal healing in Crohn's disease: case report.
    Leite MR; Santos SS; Lyra AC; Mota J; Santana GO
    World J Gastroenterol; 2011 Dec; 17(45):5028-31. PubMed ID: 22174554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review.
    Scribano ML; Cantoro L; Marrollo M; Cosintino R; Kohn A
    J Clin Gastroenterol; 2014 Jul; 48(6):530-3. PubMed ID: 24667589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.